Provided by Tiger Trade Technology Pte. Ltd.

Teva Pharmaceutical

36.85
+0.09000.24%
Pre-market: 36.60-0.2500-0.68%08:35 EDT
Volume:4.00M
Turnover:147.20M
Market Cap:42.93B
PE:61.42
High:37.32
Open:36.82
Low:36.47
Close:36.76
52wk High:38.37
52wk Low:18.21
Shares:1.17B
Float Shares:1.09B
Volume Ratio:0.74
T/O Rate:0.37%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.6000
EPS(LYR):1.21
ROE:9.69%
ROA:5.13%
PB:5.54
PE(LYR):30.45

Loading ...

Jan 28, 2026

Major Issues Report

Form 8-K - Current report
Jan 12, 2026

Major Issues Report

Form 8-K - Current report
Dec 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 11, 2025

Major Issues Report

Form 8-K - Current report
Dec 09, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 09, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 26, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 20, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 14, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 05, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 05, 2025

Major Issues Report

Form 8-K - Current report
Sep 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 30, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 30, 2025

Major Issues Report

Form 8-K - Current report
Jun 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 05, 2025

Major Issues Report

Form 8-K - Current report
Jun 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 28, 2025

Major Issues Report

Form 8-K - Current report